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Current knowledge of the genetic diversity of simian immunodeficiency virus (SIVcpz) infection of wild
chimpanzees (Pan troglodytes) is incomplete since few isolates, mostly from captive apes from Cameroon and
Gabon, have been characterized; yet this information is critical for understanding the origins of human
immunodeficiency virus type 1 (HIV-1) and the circumstances leading to the HIV-1 pandemic. Here, we report
the first full-length SIVcpz sequence (TAN1) from a wild chimpanzee (Pan troglodytes schweinfurthii) from
Gombe National Park (Tanzania), which was obtained noninvasively by amplification of virion RNA from fecal
samples collected under field conditions. Using reverse transcription-PCR and a combination of generic and
strain-specific primers, we amplified 13 subgenomic fragments which together spanned the entire TAN1
genome (9,326 bp). Distance and phylogenetic tree analyses identified TAN1 unambiguously as a member of the
HIV-1/SIVcpz group of viruses but also revealed an extraordinary degree of divergence from all previously
characterized SIVcpz and HIV-1 strains. In Gag, Pol, and Env proteins, TAN1 differed from west-central
African SIVcpz and HIV-1 strains on average by 36, 30, and 51% of amino acid sequences, respectively,
approaching distance values typically found for SIVs from different primate species. The closest relative was
SIVcpzANT, also from a P. t. schweinfurthii ape, which differed by 30, 25, and 44%, respectively, in these same
protein sequences but clustered with TAN1 in all major coding regions in a statistically highly significant
manner. These data indicate that east African chimpanzees, like those from west-central Africa, are naturally
infected by SIVcpz but that their viruses comprise a second, divergent SIVcpz lineage which appears to have
evolved in relative isolation for an extended period of time. Our data also demonstrate that noninvasive
molecular epidemiological studies of SIVcpz in wild chimpanzees are feasible and that such an approach may
prove essential for unraveling the evolutionary history of SIVcpz/HIV-1 as well as that of other pathogens
naturally infecting wild primate populations.
West-central African chimpanzees (Pan troglodytes troglo-
dytes) are naturally infected with strains of simian immunode-
ficiency virus (SIVcpz) that represent the closest relatives of
human immunodeficiency virus type 1 (HIV-1) groups M, N,
and O and have thus been implicated as the primate source of
the human infections (12). East African chimpanzees (Pan
troglodytes schweinfurthii) are also infected with SIVcpz, but
genetic information for these viruses is limited since only two
such strains (ANT and TAN1) have so far been identified (32,
45). The first of these, SIVcpzANT, was isolated over a decade
ago from a wild-caught chimpanzee orphan (Noah) which was
confiscated upon illegal exportation from Kinshasa (Demo-
cratic Republic of Congo) (26). Although its geographic origin
is unknown, this chimpanzee was subsequently typed as an
eastern chimpanzee (P. t. schweinfurthii) by mitochondrial
DNA analysis (12). SIVcpzANT was completely sequenced
and found to be most closely related to members of the
SIVcpz/HIV-1 group of viruses; however, phylogenetic analysis
revealed that it formed a highly divergent outgroup to all
previously characterized SIVcpz and HIV-1 strains (45). The
second P. t. schweinfurthii virus, SIVcpzTAN1, was discovered
only recently in a wild chimpanzee (Ch-06) from Gombe Na-
tional Park in Tanzania (32). Using noninvasive detection
methods, we identified SIVcpz-specific antibodies in urine
samples and confirmed SIVcpz infection by amplifying viral
sequences from fecal RNA. Again, sequence analysis indicated
infection with a highly divergent SIVcpz strain (32); however,
the availability of only partial pol-vif sequences precluded a
conclusive phylogenetic analysis. In this paper, we describe
a novel reverse transcription-PCR (RT-PCR) strategy al-
lowing the amplification of the complete SIVcpzTAN1 se-
quence from fecal samples of chimpanzee Ch-06. Analysis of
this sequence revealed new insight into the evolutionary
history of the HIV-1/SIVcpz group of viruses and provided
conclusive evidence for the existence of two divergent
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SIVcpz lineages infecting chimpanzees in west-central and
east Africa, respectively.
Chimpanzee Ch-06 was a healthy, 24-year-old, sexually ac-
tive, midranking male member of the Kasekela community,
which comprises approximately 55 individuals and is the largest
in Gombe National Park. All community members live freely
but are habituated to the presence of human observers (14).
They are individually known and named and are routinely
studied at close distances. Fecal samples were collected from
chimpanzee Ch-06 on three independent occasions (9 Novem-
ber 2000, 11 November 2000, and 18 November 2000) under
direct observation by field researchers from the Gombe Stream
Research Centre. (Fieldwork in Gombe National Park was
authorized by the Tanzania Commission for Science and Tech-
nology, the Tanzania Wildlife Research Institute, and the Tan-
zania National Parks.) Approximately 20 g of fecal material
was placed into a 50-ml tube containing 20 ml of RNAlater
(Ambion, Austin, Tex.). RNAlater preserves nucleic acids, al-
lowing storage and shipment at room temperature without
viral RNA degradation. Tubes were sealed with Parafilm, ini-
tially stored at 20°C, and then shipped at ambient tempera-
ture to the United States by air carrier. Upon arrival, fecal
suspensions were aliquoted and stored at 70°C, and RNA
was extracted with the RNAqueous-Midi kit (Ambion) accord-
ing to the manufacturer’s recommendations. Briefly, fecal ali-
quots (1 ml) were resuspended in lysis buffer (6 ml), vortexed,
and centrifuged (16,000  g; 3 min) to remove solid debris.
Clarified supernatants were mixed with an equal volume of
64% ethanol and passed through a glass fiber filter unit to bind
nucleic acids. Following extensive washes, bound nucleic acids
were eluted (1 ml), precipitated with LiCl2 to enrich for RNA
and to remove potential PCR inhibitors, pelleted, and resus-
pended in 50 l of distilled water. RNA extracts were stored at
70°C.
Previous studies of HIV-1- and SIVcpz-infected chimpan-
zees as well as HIV-1-infected humans had shown that viral
RNA, but not proviral DNA, was detectable in fecal samples,
suggesting that viral nucleic acids were present in virions and
not in infected cells (32, 46). We thus used an RT-PCR ap-
proach with consensus and strain-specific primers to amplify
partially overlapping subgenomic (400- to 2,000-bp) viral frag-
ments in a stepwise fashion to derive a complete SIVcpz se-
quence (Fig. 1). For cDNA synthesis, 10 l of extracted fecal
RNA was added to an RT-PCR master mix consisting of 1
buffer II (Perkin-Elmer, La Jolla, Calif.), 5 mM MgCl2, 1 mM
deoxynucleoside triphosphate, 5 mM dithiothreitol, 20 pmol of
reverse primer (Table 1), 20 U of RNase inhibitor (Promega,
Madison, Wis.), and 100 U of Superscript RT II (Gibco-BRL,
Rockville, Md.) and incubated for 1 h at 42°C. Ten microliters
of this cDNA preparation was then added to a PCR mix con-
sisting of Expand Buffer 2 (Roche Molecular Biochemicals,
Indianapolis, Ind.), 0.35 mM deoxynucleoside triphosphate,
2.25 mM MgCl2, 0.1 g of bovine serum albumin/ml, 2.5 U of
Expand high-fidelity Taq polymerase (Roche Molecular Bio-
chemicals), and 10 pmol of forward and reverse primers (Table
1) and subjected to nested (or seminested) PCR amplifica-
tions. Amplification conditions included 45 cycles of denatur-
ation (94°C, 0.5 min), annealing (50°C, 0.5 min), and elonga-
tion (68°C, 1.5 min). Two microliters of the first-round reaction
mixture was used for second-round amplification under the
same thermocycling conditions.
Targeting regions of high sequence conservation, we initially
amplified a 650-bp fragment in the integrase region of pol and
a 782-bp fragment spanning the gp41-nef junction (fragments 1
and 2 in Fig. 1). SIVcpzTAN1 strain-specific primers were then
combined with upstream and downstream consensus primers
to obtain sequences 3 and 5 of these anchor fragments (Table
1). Fragments of 1,000 bp or less were readily amplified. How-
ever, attempts to amplify longer fragments were generally un-
successful, except for a 2,197-bp envelope fragment which was
obtained with SIVcpzTAN1-specific primers. To obtain the 3
terminus of the viral genome, we used oligo(dT)18 for cDNA
synthesis, followed by amplification with consensus primers in
the repeat (R) region of the long terminal repeat (LTR). This
yielded a 742-bp fragment (fragment 12) that included the
complete U3 and parts of the R region of the 3 LTR. Se-
quences specific for the R region were then used to design
primers to amplify the 5 terminus (fragment 13). By this strat-
egy, an entire genomic equivalent of SIVcpzTAN1 was ob-
tained in 13 partially overlapping fragments. PCR products
FIG. 1. Amplification of a complete SIVcpzTAN1 sequence from chimpanzee fecal RNA. RT-PCR was used to amplify partially overlapping
subgenomic fragments from virion RNA extracted from two independent fecal samples collected on 9 November 2000 and 11 November 2000 from
chimpanzee Ch-06 under direct observation. The relative positions of the fragments with respect to the SIVcpzTAN1 genome, along with their
order of amplification, are shown. Fragment lengths are drawn to scale (the entire SIVcpzTAN1 sequence is 9,326 bp in length). The first two
fragments, which were derived with consensus primers from highly conserved regions of the HIV-SIV genome, are highlighted in red. Sequences
of fragments 1, 3, and 4 have been reported previously (32).
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were visualized by gel electrophoresis, purified (Qiagen, Va-
lencia, Calif.), and sequenced without interim cloning, except
for fragments 12 and 13, which were cloned into a plasmid
(pTOPO) vector (Invitrogen, Carlsbad, Calif.) to obtain viral
sequences immediately adjacent to the primer sequences. Viral
sequences were assembled with Sequencher software (Gene
Codes Corporation, Ann Arbor, Mich.). None of the directly
sequenced fragments yielded ambiguous bases, suggesting am-
plification of viral sequences at limiting dilution conditions.
However, a limited number of nucleotide sequence differences
were noted between adjoining fragments in the region of se-
quence overlap, consistent with the presence of SIVcpz as a
quasispecies in fecal samples (46). In these cases, the 5 se-
quence was arbitrarily selected for compilation of the final
SIVcpzTAN1 sequence. The concatenated SIVcpzTAN1 ge-
nome (R-U5-gag-pol-env-U3-R) was 9,326 bp in length.
Inspection of deduced protein sequences of SIVcpzTAN1
revealed the expected reading frames for gag, pol, vif, vpr, vpu,
tat, rev, env, and nef, none of which contained inactivating
mutations. In addition, major regulatory sequences, including
promoter and enhancer elements in the LTR, the transactiva-
tion region stem-loop structure, the packaging signal, the
primer binding site, and major splice sites all appeared to be
intact. The deduced TAN1 Vpu amino acid sequence was
highly divergent from those of other HIV-1 or SIVcpz Vpu
proteins. For example, ANT and TAN1 Vpu proteins were
only 37% identical (Fig. 2A). However, the position of the vpu
open reading frame in the TAN1 genome (Fig. 1) and the
hydrophobicity profile of its deduced protein sequence (Fig.
2B) were very similar to those of other HIV-1 and SIV strains
(8, 41). In addition, secondary structure predictions suggested
the presence of alpha helices near the C terminus that flanked
two highly conserved serine residues (Fig. 2A) previously
shown to be critical for HIV-1 Vpu-mediated CD4 degradation
(41). Together, these data suggest that TAN1 encodes a func-
tional Vpu protein.
To compare SIVcpzTAN1 to previously characterized
SIVcpz and HIV-1 strains, we performed diversity plot analy-
ses of concatenated protein sequences. Pairwise sequence dis-
tances were plotted for windows of 300 amino acids, moved in
steps of 20 along the alignment. Figure 3 depicts distance plots
illustrating the proportion of amino acid sequence differences
between SIVcpzTAN1 and SIVcpzGAB1 (green solid line),
U455 (HIV-1 group M; black solid line), MVP5180 (HIV-1
group O; blue solid line), and SIVcpzANT (red solid line),
revealing an extent of sequence diversity between members of
the HIV-1/SIVcpz group that is comparable to that observed
for SIVs from pairs of closely related monkey species (the
distances of SIVs from vervet and grivet monkeys, and from
l’hoest and solatus monkeys, are shown for comparison as red
and blue dotted lines, respectively; note that these viruses
differ even less than the various SIVcpz and HIV-1 strains in
the Env protein). The virus most similar to SIVcpzTAN1 was
SIVcpzANT, but even this strain was quite divergent, with
distance values ranging from 17% in Gag to 35% in Env.
Phylogenetic analyses of Gag, Pol, and Env protein sequences
TABLE 1. Oligonucleotide primers used to amplify SIVcpzTAN1 fragments comprising a complete genomic equivalent
Fragmenta Forward primerb (name; sequence) Reverse primerb,c (name; sequence) Sized
1 CON-1F1; CCAGCNCACAAAGGNATAGGAGG CON-1R1; ACBACYGCNCCTTCHCCTTTC 650
CON-1F1; CCAGCNCACAAAGGNATAGGAGG CON-1R2; CCCAATCCCCCCTTTTCTTTTAAAATT
2 CON-2F1; AAATGGCTGTGGTATATAAAAAT CON-2R1; CCCWTCCAGTCCCCCCTTTTC 782
CON-2F2; GCTTAAGAAAGGTTAGGCAGGG CON-2R2; TCCCCCCTTTTCTTTTAAAAA
3 CON-3F1; ATYTAYCARTAYATGGATGA TAN1-3R1; ATTACTGTGATATTTATCATG 944
CON-3F2; GGAAARYTAAATTGGGCAAGTC TAN1-3R2; ATTTATCATGGTCTTCCTGTGC
4 TAN1-4F1; CATACCAGAAGAAACAGGAA CON-4R1; CTGGKGCTTGTTCCATCTATC 1,058
TAN1-4F2; AATTGGCAGGAAGATGGCCTG CON-4R1; CTGGKGCTTGTTCCATCTATC
5 CON-5F1; CAGCGACARTAACGCTGACGG TAN1-5R1; GCTGTTCTGGATCCTGCTCCGC 576
CON-5F2; ACAATTATTGTCTGGTATAGTGCAACAGCA TAN1-5R2; CGCTTGGGTAGGGATCTGTG
6 CON-6F1; ATTAAAACCAGGAATGGATGG TAN1-6R1; TATCTGATATGTCCACTGTCCT 948
CON-6F2; CCAAGAGTAAARCAATGGCC TAN1-6R2; GCCCCTGCTTCTGTATTGCTGC
7 TAN1-7F1; AAGAATATTGACATTCTGCCACT CON-7R1; TACTGCTTTGGTAYAGGATCTTGA 533
TAN1-7F2; CAATCAGGACACAGACAGGTAGGGAC CON-7R2; CGCTTCTTCCTGCCATAGGA
8 CON-8F1; ACAGGAWGTRAAAAAYTGGATGAC TAN1-8R1; GGTTTTCTGGTCCAACTGCAGA 849
CON-8F2; ATGATGACAGCTTGTCAAGGAGT TAN1-8R2; GTCTTACATATTTCTGTTAATGCC
9 TAN1-9F1; GGAACAAGCACCGAACGACAAC TAN1-9R1; GCACATCCCCAGAGGCTTAGG 2,197
TAN1-9F2; CACTATCGCCATGGTTGTAT TAN1-9R2; AGCTGTTGGTCTCTTATGT
10 CON-10F1; CCMAGAACCTTAAATGCCTGGGT TAN1-10R1; AGAATCTTTGCCTTATGAGAGGGT 494
CON-10F2; RGAAGTMATCAATGAGGAAGC TAN1-10R1; AGAATCTTTGCCTTATGAGAGGGT
11 CON-11F1; AACCTGTGACGCCAGGACTCG TAN1-11R1; CCTTGTGCCTGTGGGGTTGTC 752
CON-11F2; GAAGATGGGTGCGAGAGCGTC TAN1-11R2; CCTGCTTGCTGGGGTCCTG
12 TAN1-12F1; AAGATCTTCATAACACCTCA CON-12R1; AAGCTTTATTGAGCATTAAG 742
TAN1-12F2; GGACAGGCCTCACAAGA CON-12R2; TTGAGCATTAAGAAGCAGGGTCTCC
13 TAN1-13F1; CTGGGAGCTCTCTGGTAGT TAN1-13R1; ACGCTGTAGTTCGCTTCC 368
TAN1-13F2; CTCTGGTAGTGGCTGGCT TAN1-13R2; TTCCCATGTATCCAGCTTATCTCC
a See Fig. 1 for position in SIVcpzTAN1 genome.
b CON primers were designed according to HIV-1-SIVcpz consensus sequences (20); TAN1 primers are strain specific. F1, first-round forward primer; F2,
second-round forward primer; R1, first-round reverse primer; R2, second-round reverse primer. R  A/G, Y  C/T, M  A/C, K  G/T, S  C/G, W  A/T, H 
A/C/T, B  C/G/T, V  A/C/G, D  A/G/T, and N  A/C/T/G.
c First-round reverse primers were also used for cDNA synthesis, except for fragment 12, where oligo(dT)18 was used (see text for details).
d Size of nested (or seminested) PCR fragments (in base pairs).
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confirmed these relationships (Fig. 4), demonstrating that
SIVcpzTAN1 fell within the HIV-1/SIVcpz radiation and
grouped most closely with SIVcpzANT. This phylogenetic po-
sition was consistent in all major coding regions and supported
by significant bootstrap values (Fig. 4). Distance and phyloge-
netic analyses thus identified SIVcpzTAN1 as a highly diver-
gent member of the HIV-1/SIVcpz group of viruses. Since,
until now, there has been only a single divergent P. t. schwein-
furthii strain from a captive chimpanzee (Noah) of unknown
origin, the possibility existed that SIVcpzANT was the result of
a cross-species transmission event from another primate spe-
cies and did not really represent a virus naturally infecting
chimpanzees. The derivation of the complete SIVcpzTAN1
sequence from a chimpanzee of unquestionable provenance
renders this possibility improbable. The phylogenetic position
of TAN1 in Fig. 4 confirms the authenticity of SIVcpzANT as
a bona fide SIVcpz strain and thus provides conclusive evi-
dence for the existence of two major lineages within the
SIVcpz/HIV-1 radiation.
We next inspected SIVcpz and HIV-1 protein alignments for
lineage-specific amino acid sequence insertions and deletions
because such features are excluded from phylogenetic analy-
ses. This analysis identified several signatures that distin-
guished ANT and TAN1 from all other SIVcpz and HIV-1
strains (Fig. 5). For example, both ANT and TAN1 contained
an identical 5-amino-acid insertion (KGPRR) near the C ter-
minus of Vif which disrupted a highly conserved PPLP motif
previously shown to be critical, in its entirety, for HIV-1 Vif
function (38). In addition, they exhibited a 5-amino-acid dele-
tion near the C terminus of Nef that included a diacidic -COP
(coatomer protein) binding motif shown elsewhere to be im-
portant for HIV-1 Nef-induced CD4 degradation (30). Both
ANT and TAN1 also encoded a considerably truncated Vpr
protein that lacked several basic residues at the C terminus
previously shown to be important for HIV-1 Vpr-induced nu-
clear localization and G2 cell cycle arrest, including a critical
Arg-90 residue (9, 34, 47). Since accessory protein functions
are highly conserved among divergent SIV lineages (19, 37,
40), it is highly unlikely that the Vif, Vpr, and Nef proteins of
the two P. t. schweinfurthii viruses have lost these functions
(this is especially true for TAN1, which was derived without the
in vitro selection that might occur through growth in human
T-cell lines). Instead, the observed Vif, Vpr, and Nef mutations
are likely compensated by amino acid substitutions elsewhere
in these proteins. Finally, both ANT and TAN1 exhibited an
amino acid sequence insertion (8 amino acids for ANT; 9
amino acids for TAN1) in the ectodomain of the transmem-
brane envelope glycoprotein (gp41) which is flanked by two
additional cysteine residues (Fig. 5). Unpaired cysteines are
known to interfere with the proper folding of the SIV and HIV
envelope glycoproteins (22, 42, 44). It is thus likely that the
additional cysteine residues in TAN1 and ANT gp41 form
intermolecular disulfide bonds, possibly resulting in an addi-
tional surface loop that might alter the local gp41 structure.
Since this region is also known to be involved in gp120-gp41
interactions (5, 33), it is possible that compensatory changes in
the N or C terminus of gp120 have evolved in association with
these mutations. Construction of a replication-competent
TAN1 genome and functional analyses of its gene products will
allow us to examine these possibilities experimentally. Inter-
FIG. 2. Genetic diversity of Vpu in SIVcpz from P. t. schweinfurthii. (A) Alignment of the TAN1 and ANT Vpu sequences reveals an
extraordinary degree of diversity (identical residues are indicated by asterisks) but demonstrates conservation of two serine residues (denoted by
arrows) previously shown to be critical for HIV-1 Vpu-induced CD4 degradation (41). (B) Hydrophobicity profiles of SIVcpzTAN1 and
SIVcpzANT Vpu proteins (calculated with the Kyte and Doolittle algorithm [21]) suggest similar secondary structures. Positive scores indicate
degrees of hydrophobicity. The x axis shows the number of amino acid residues along the protein.
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estingly, the extra cysteine pair in gp41, the truncated Vpr, and
the Vif insertion were absent not only from SIVcpz from P. t.
troglodytes but also from all other SIVs, including the relatively
more closely related (at least in env) SIVgsn strain (8). This
would suggest that P. t. schweinfurthii viruses acquired these
changes some time after their divergence from the common
SIVcpz ancestor but before the split of the lineages repre-
sented by today’s SIVcpzTAN1 and SIVcpzANT. In addition,
the absence of these signatures from all known HIV-1 variants
(groups M, N, and O) is consistent with their west-central
African chimpanzee (P. t. troglodytes) origin.
We previously interpreted the host-specific clustering of P. t.
troglodytes and P. t. schweinfurthii viruses as indicating a long-
standing virus-host relationship, possibly predating the diver-
gence of these two chimpanzee subspecies hundreds of thou-
sands of years ago (12, 15). Although the phylogenetic position
of SIVcpzTAN1 is consistent with this interpretation, recent
molecular clock calculations using more realistic models of
HIV and SIV sequence evolution suggest a timescale for SIV
evolution that is much shorter than previously assumed (36).
For SIVcpz in particular, this estimated timescale would cer-
tainly not be on the order of hundreds of thousands or millions
of years as required for virus-host coevolution. Moreover, mi-
tochondrial DNA studies of wild chimpanzees in west-central
Africa suggest that the two equatorial subspecies are not as
distinct as previously believed (24), with P. t. schweinfurthii now
being seen to fall within the P. t. troglodytes radiation (10). It is
thus possible that SIVcpz was introduced into chimpanzees
relatively more recently, most likely by cross-species transmis-
sion of SIV from smaller monkeys that serve as a food source
for chimpanzees. The most probable location for such a trans-
mission would be west-central Africa, since it is there where
smaller monkey species have been determined to harbor re-
lated viruses (8, 13, 39). Once introduced, SIVcpz would have
likely spread eastward to P. t. schweinfurthii but probably not to
the western subspecies Pan troglodytes verus which is believed
FIG. 3. Diversity plots of concatenated protein sequences illustrating the extent of genetic diversity within the HIV-1/SIVcpz group of viruses.
The proportion of amino acid sequence differences between SIVcpzTAN1 and SIVcpzGAB1 (green solid line), SIVcpzANT (red solid line),
HIV-1/U455 (black solid line), and HIV-1/MVP5180 (blue solid line) is shown, in comparison with the proportion of amino acid sequence
differences between SIVagmVER155 and SIVagmGRI-1 (red dotted line) and SIVlhoest7 and SIVsun (blue dotted line), respectively. Predicted
protein sequences were concatenated, with C-terminal overlaps being removed and aligned with Clustal W (43) and with minor manual
adjustments being made with SEAVIEW (11). Sites that could not be unambiguously aligned, as well as sites containing a gap in any sequence,
were excluded from the alignment. Protein sequence differences (number of amino acid sequence mismatches per sequence length) were calculated
for windows of 300 amino acids, moved in steps of 20 amino acids across the concatenated alignment. The x axis indicates amino acid positions,
with the N termini of Gag, Pol, Vif, Env, and Nef denoted. The y axis denotes the distance between the viral proteins (0.1  10% differences).
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to have been geographically isolated from P. t. troglodytes and
P. t. schweinfurthii for an extended period of time (17, 24). The
absence of SIVcpz from two wild P. t. verus communities in the
Taï forest (32) as well as the lack of SIVcpz from over a
thousand captive chimpanzees of west African origin (31;
W. M. Switzer and W. Heneine, personal communication)
strongly supports this conclusion. Thus, the two major SIVcpz
lineages shown here to infect P. t. troglodytes and P. t. schwein-
furthii subspecies (Fig. 4) most likely reflect a more recent
divergence of SIVcpz within geographically isolated popula-
tions of chimpanzees rather than ancient infection of chimpan-
zees and coevolution of virus and host.
The analysis of the complete SIVcpzTAN1 sequence also
provides new insight into the origins of HIV-1 groups M, N,
and O. First, the significant clustering of SIVcpzTAN1 and
SIVcpzANT, their divergence from SIVcpz strains infecting P.
t. troglodytes, and the close phylogenetic relationship of P. t.
troglodytes viruses to HIV-1 groups M, N, and O (Fig. 4) all
reaffirm the conclusion that the HIV-1 epidemic resulted from
zoonotic transmission of SIVcpz from west-central African and
not east African chimpanzees to humans (12). Second, the
discovery of SIVcpzTAN1 and its relationships to the other
HIV-1 and SIVcpz strains provides a plausible explanation for
the unusual position of HIV-1 group O in phylogenetic trees.
Because group O viruses fall as an outgroup to (rather than
within) the clade comprised of other HIV-1 groups and SIVcpz
from P. t. troglodytes, a west-central African origin of HIV-1
group O has until now seemed less certain (12, 15, 35), even
though epidemiologically group O viruses have long been
known to be largely restricted to Cameroon and neighboring
countries (1, 4, 27). Inspection of the phylogenetic trees in Fig.
4 and comparison of HIV-1 and SIVcpz protein sequence
identities in Table 2 now reveal that, overall, HIV-1 group O
viruses are no more distant from P. t. troglodytes viruses than
the two P. t. schweinfurthii strains are from each other. To-
gether with the known demographic distribution of HIV-1
group O infections, these data argue strongly for a west-central
African chimpanzee origin of HIV-1 group O. It may then
seem surprising that all known west-central African SIVcpz
strains cluster together with HIV-1 groups M and N in a single
clade, with no SIVcpz being closely related to HIV-1 group O.
This may be due to the fact that all known P. t. troglodytes
viruses, with the possible exception of SIVcpzUS, whose geo-
graphic origin is unknown, were derived from chimpanzees
FIG. 4. Maximum likelihood tree depicting the relationship of
SIVcpzTAN1 to other primate lentiviruses. SIVcpzTAN1 predicted
protein sequences were compared to the following HIV and SIV rep-
resentatives: HIV-1 group M subtype A (U455 [GenBank accession
number M62320]) and subtype B (LAI [accession number K02013]),
group N (YBF30 [accession number AJ006022] and YBF106 [acces-
sion number AJ271370]) and group O (ANT70 [accession number
L20587] and MVP5180 [accession number L20571]), and SIVcpz
(GAB1 [accession number X52154], US [accession number
AF103818], CAM3 [accession number AF115393], CAM5 [accession
number AJ271369], and ANT [accession number U42720]). Phyloge-
netic trees were constructed by both maximum likelihood and neighbor
joining methods and rooted by using SIVmndGB1 as an outgroup
(M27470). The neighbor joining method was implemented in Clustal
W (43) with Kimura’s empirical correction (18) and 1,000 boot-
strapped replicates. The maximum likelihood method was imple-
mented in PROTML from the MOLPHY package (J. Adachi and M.
Hasegawa, Institute of Statistical Mathematics, Tokyo, Japan, 1994) by
using a quick search and the Jones, Taylor, and Thornton model for
amino acid substitution (16) with amino acid frequencies. SIVcpz
strains from P. t. troglodytes are shown in red, and those from P. t.
schweinfurthii are shown in blue, with SIVcpzTAN1 highlighted. Hor-
izontal branch lengths are drawn to scale. The scale bar indicates 0.1
substitution per site. Asterisks denote branches (and thus the clades to
their right) supported by more than 85% of bootstrapped replicates in
trees made by the neighbor joining method.
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captured in southern Cameroon or northern Gabon in a region
south of the Sanaga River and north of the Ogooue´ River (7,
28). Since HIV-1 groups M and N fall within the radiation of
these chimpanzee viruses, it is likely that the cross-species
transmission events giving rise to these HIV-1 groups took
place in the same vicinity. The SIVcpz predecessor of HIV-1
group O would then be expected to have come from a different
geographic region, yet still within west-central Africa. An in-
triguing possibility is that HIV-1 group O originated in the
fourth (Nigerian) subspecies of chimpanzees, Pan troglodytes
vellerosus, whose natural habitat includes eastern Nigeria and
western Cameroon with the Sanaga River delineating its south-
ern boundary (6, 10). Evidence of rare chimpanzee gene flow
across the Sanaga River has been reported elsewhere (10),
FIG. 5. SIVcpz lineage-specific protein signatures. Alignments of SIVcpz and HIV-1 Vif, Nef, Vpr, and gp41 deduced amino acid sequences
are shown for selected regions of the proteins. Sequences are compared to SIVcpzTAN1, with dashes denoting sequence identity and dots
representing gaps introduced to optimize the alignment. Question marks indicate sites of ambiguous sequence (in SIVcpz) or sites at which fewer
than 50% of the viruses contain the same amino acid residue (in HIV-1). Pound signs indicate stop codons. HIV-1 group M, N, and O sequences
are consensus sequences obtained from the Los Alamos HIV Sequence Database (http://hiv-web.lanl.gov) (20). For HIV-1 group M, consensus
subtype A sequences are shown; however, consensus sequences from the other subtypes yielded the same results (data not shown). Vertical boxes
highlight SIVcpz lineage-specific protein signatures in Vif, Vpr, Nef, and gp41. Arrows denote a pair of cysteine residues in the ectodomain of gp41
that is unique to P. t. schweinfurthii viruses (the horizontal line denotes the immunodominant region of the HIV-1 gp41 glycoprotein). Asterisks
indicate a highly conserved PPLP motif in Vif, a diacidic -COP binding motif in Nef, and four C-terminal Arg residues in Vpr (Arg-90 is circled),
previously shown to be critical for protein function in HIV-1 (see the text for details). Consistent with their proposed origin (12), HIV-1 groups
M, N, and O exhibit protein features characteristic of SIVcpz from P. t. troglodytes.
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offering the possibility that SIVcpz could have spread from P.
t. troglodytes to P. t. vellerosus in the past. Naturally infected P.
t. vellerosus apes have not yet been identified, but only very few
have been tested. Comprehensive screening of these chimpan-
zees and others throughout west-central Africa for SIVcpz
infection is needed to test this hypothesis.
The documentation of SIVcpzTAN1 in Gombe extends the
geographic range of SIVcpz from Gabon and Cameroon across
equatorial Africa to Tanzania. Although additional field stud-
ies throughout west-central and east Africa will be required to
understand fully the geographic distribution and prevalence of
SIVcpz in P. t. troglodytes and P. t. schweinfurthii, the present
results make it most likely that both of these subspecies are
endemically infected. We considered the possibility that Ch-06
could have been infected by HIV-1 from an infected human, or
by SIV from another primate species, but found both scenarios
implausible. First, none of the Gombe chimpanzees has ever
been held captive, relocated from a different part of Africa, or
inoculated with human blood; even had they been exposed to
blood or bodily secretions from an infected human, there are
no known HIV-1 strains that are at all closely related to
SIVcpzTAN1 (Fig. 4). Second, among over 30 African primate
species known to harbor SIV, none have been found to carry
viruses that are sufficiently closely related to SIVcpz to repre-
sent a viable direct source (15, 25). Third, to explain an infec-
tion of Ch-06 by an SIV from another primate species would
require, on phylogenetic grounds, the same as yet unidentified
primate reservoir to have transmitted similar viruses to both
chimpanzees and humans on as many as 10 different occasions.
Such a hypothetical primate species, whose habitat would also
need to overlap the range of both P. t. troglodytes and P. t.
schweinfurthii, is unlikely given the results of the rather exten-
sive surveys of primates for HIV-1-related infections that have
already been conducted (2, 25). Thus, human-to-chimpanzee
transmission of an SIVcpz-like virus cannot be invoked to
explain the existence of SIVcpzTAN1, and an additional con-
current primate reservoir is highly improbable.
There remain a number of questions regarding the preva-
lence, subspecies distribution, and evolutionary history of
SIVcpz in chimpanzees. Although six additional SIVcpz-in-
fected chimpanzees have recently been identified in Gombe
National Park (M. L Santiago and B. H. Hahn, unpublished
data), other communities in east Africa appear to be free of
infection, indicating, overall, a surprisingly low prevalence of
SIVcpz in east African chimpanzees. Moreover, even within an
infected community like Kasekela, spread of SIVcpz from the
single index case has not yet been documented (Santiago and
Hahn, unpublished). This is in stark contrast to SIV infection
of smaller primate species, where prevalence increases with
age in wild troops and up to 90% of sexually active adults
become infected (3, 25, 29). Additional field studies of wild-
living chimpanzees are clearly needed to shed light on these
and other issues. It is possible that studies of SIVcpz infection
in wild chimpanzee communities will help explain not only the
pathogenicity of HIV-1 in humans but also its current trans-
mission rates, which have led to the AIDS pandemic. In a
practical sense, the present study demonstrates that full-length
SIVcpz sequences can be derived noninvasively and that blood
sampling is not required to conduct comprehensive molecular
epidemiological studies of primate lentiviruses in endangered
species. Moreover, it has been shown that this noninvasive ap-
proach is applicable to other viral infections and primate pop-
ulations (23). This should provide new opportunities for pri-
matologists, conservationists, and biomedical scientists to
combine their research efforts to study medically important
pathogens and emerging infectious diseases.
Nucleotide sequence accession number. The GenBank ac-
cession number for the concatenated SIVcpzTAN1 genome
sequence (R-U5-gag-pol-env-U3-R) is AF447763.
TABLE 2. Protein sequence identities between different HIV-1 and SIVcpz groups of viruses
Comparison
Avg % (range) protein sequence identity
Gag Pol Vif Vpr Tat Rev Vpu Env Nef
SIVcpz (P.t.t.) vs
SIVcpz
(P.t.t.)a
83 (79–89) 90 (82–94) 74 (68–84) 83 (77–89) 68 (62–83) 64 (50–76) 46 (33–67) 69 (63–77) 80 (77–82)
HIV-1 M vs
SIVcpz
(P.t.t.)b
73 (71–75) 82 (80–85) 70 (66–74) 81 (74–88) 64 (56–76) 59 (48–67) 31 (20–40) 61 (59–64) 70 (65–76)
HIV-1 N vs
SIVcpz
(P.t.t.)c
75 (74–77) 83 (81–84) 72 (64–76) 83 (79–88) 69 (65–71) 62 (55–70) 37 (29–47) 69 (64–73) 72 (69–77)
HIV-1 O vs
SIVcpz
(P.t.t.)d
71 (70–72) 77 (76–79) 67 (62–69) 78 (75–82) 53 (49–57) 46 (41–50) 32 (28–35) 51 (50–52) 61 (58–62)
SIVcpz (P.t.s.) vs
SIVcpz
(P.t.t.)e
65 (63–68) 71 (70–73) 57 (53–61) 62 (59–65) 52 (49–57) 45 (38–53) 20 (16–26) 49 (46–52) 55 (53–57)
SIVcpzTAN1 vs
SIVcpzANT
70 75 64 73 57 55 37 56 68
a SIVcpz viruses from P. t. troglodytes (P.t.t.) include GAB1, US, CAM3, and CAM5.
b HIV-1 group M includes U455, LAI, ELI, C2200, CF506, and V1850.
c HIV-1 group N includes YBF30 and YBF160.
d HIV-1 group O includes MVP5180 and ANT70.
e SIVcpz viruses from P. t. schweinfurthii (P.t.s.) include ANT and TAN1.
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